1 Alpha-hydroxyvitamin D3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosourea in rats

Cancer Lett. 1990 Dec 3;55(2):149-52. doi: 10.1016/0304-3835(90)90025-s.

Abstract

The effect of 1 alpha-hydroxyvitamin D3 (1 alpha (OH)D3) on colonic tumorigenesis induced by chronic treatment with N-methyl-N-nitrosourea (MNU) was studied in rats. Seventy-four female F344 rats received an intrarectal injection of 1 mg of MNU once a week for 40 weeks. Two-thirds of rats were given concomitant administration of 0.2 ml of medium chain triglyceride (MCT) or MCT containing 0.04 microgram of 1 alpha (OH)D3 through an intragastric route thrice weekly. Numbers of rats bearing colonic tumor were 21 in MNU alone (n = 24), 17 in MNU + MCT (n = 25) and 12 in MNU + 1 alpha (OH)D3 group (n = 25) (uncorrected chi 2 = 8.72). The result indicated that colonic tumorigenesis induced by the chronic treatment with MNU was suppressed by oral supplementation of 1 alpha (OH)D3 and the inhibitory effect of 1 alpha (OH)D3 was partly due to the effect of MCT.

MeSH terms

  • Adenoma / chemically induced
  • Adenoma / drug therapy
  • Adenoma / epidemiology
  • Administration, Rectal
  • Animals
  • Body Weight / drug effects
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / epidemiology
  • Female
  • Hydroxycholecalciferols / pharmacology*
  • Incidence
  • Methylnitrosourea / administration & dosage
  • Rats
  • Rats, Inbred F344

Substances

  • Hydroxycholecalciferols
  • Methylnitrosourea
  • alfacalcidol